First Time Loading...
S

Shandong Pharmaceutical Glass Co Ltd
SSE:600529

Watchlist Manager
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Watchlist
Price: 26.3 CNY -1.98% Market Closed
Updated: May 29, 2024

Shandong Pharmaceutical Glass Co Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shandong Pharmaceutical Glass Co Ltd
Total Equity Peer Comparison

Comparables:
1066
603658
300888
300832
300595

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
S
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Total Equity
¥7.5B
CAGR 3-Years
19%
CAGR 5-Years
16%
CAGR 10-Years
14%
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Total Equity
¥22.4B
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Autobio Diagnostics Co Ltd
SSE:603658
Total Equity
¥8.5B
CAGR 3-Years
9%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Total Equity
¥11.5B
CAGR 3-Years
3%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Total Equity
¥7.5B
CAGR 3-Years
16%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Autek China Inc
SZSE:300595
Total Equity
¥4.4B
CAGR 3-Years
32%
CAGR 5-Years
32%
CAGR 10-Years
N/A

See Also

What is Shandong Pharmaceutical Glass Co Ltd's Total Equity?
Total Equity
7.5B CNY

Based on the financial report for Mar 31, 2024, Shandong Pharmaceutical Glass Co Ltd's Total Equity amounts to 7.5B CNY.

What is Shandong Pharmaceutical Glass Co Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
14%

Over the last year, the Total Equity growth was 6%. The average annual Total Equity growth rates for Shandong Pharmaceutical Glass Co Ltd have been 19% over the past three years , 16% over the past five years , and 14% over the past ten years .